Application of the isolated perfused rat kidney model to assess gender effects on drug excretion

Drug Development and Industrial Pharmacy

Volumn 32, Issue 8, 2006, Pages 919-928

  Taft, D R ^a   Dontabhaktuni, A ^a   Babayeva, M ^a   Nakatani Freshwater, T ^a   Savant, I A ^b  

^a LONG ISLAND UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; FUROSEMIDE;

ANIMAL EXPERIMENT; ARTICLE; DRUG EXCRETION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INULIN CLEARANCE; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY MASS; MALE; NONHUMAN; RAT; RAT STRAIN; SEX ROLE; SODIUM ABSORPTION; URINARY EXCRETION;

ANIMALS; FEMALE; FUROSEMIDE; GLOMERULAR FILTRATION RATE; KIDNEY; MALE; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; P-AMINOHIPPURIC ACID; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

EID: 33748484914     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500530018     Document Type: Article

References (35)

1. Bekersky, I. (1983). The isolated perfused kidney as a pharmacological tool. Trends. Pharmacol. Sci., 4, 6-7.
2. Bowman, R. H. (1975). The perfused rat kidney. Methods Enzymol, 39, 3-11.
3. Bowman, R. H. (1978). Methodology for the study of isolated perfused rat kidney in vitro. In M. Maldonato (Ed.), Methods in pharmacology: Renal pharmacology (pp. 50-77). New York: Plenum.
4. Brandoni, A., Villar, S. R., & Torres, A. M. (2004). Gender-related differences in the pharmacodynamics of furosemide in rats. Pharmacology, 70, 107-112.
5. Buist, S. C. N., Cherrington, N. J., Choudhuri, S., Hartley, D.P., & Klaassen, C.D. (2002). Gender-specific and developmental influences on the expression of rat organic anion transporters. J. Pharmacol. Exp. Ther., 301, 145-151.
6. Burckhardt, B. C., & Burckhardt, G. (2003). Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev. Physiol. Biochem. Pharmacol., 146, 95-158.
7. Burckhardt, G., Bahn, A., & Wolff, N.A. (2001). Molecular physiology of renal p-aminohippurate secretion. News Physiol. Sci., 15, 114-118.
8. Cerrutti, J. A., Quaglia, N. B., Brandoni, A., & Torres, A. M. (2002). Effect of gender on the pharmacokinetics of drugs secreted by the renal organic anions transport system in the rat. Pharmacol. Res., 45, 107-112.
9. Dresser, M. J. Leabman, M. K., & Giacomini, K. M. (2001). Transporters involved in the renal elimination of drugs in the kidney: Organic anion transporters and organic cation transporters. J. Pharm. Sci., 90, 397-421.
10. Inui, K., Masuda, S., & Saito, H. (2000). Cellular and molecular aspects of drug transport in the kidney. Kidney Int., 58, 944-958.
11. Kahn, J., Lagakos, S., Wulfsohn, N., Cherng, D., Miller, M. D., Cherrington, J. M., Hardy, D., Beall, G., Cooper, R., Murphy, R., Basgoz, N., Ng, E., Deeks, S., Winslow, D., Toole, J. J., & Coakley, D. (1999). Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: A randomized controlled trial. J. Am. Med. Assoc., 282, 2305-2312.
12. Komiya, R., Sekine, K., Kawachi, M., Cha, S. H., Suzuki, Y., & Endou, H. (2002). Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3 in rat kidney. J. Am. Soc. Nephrol., 13, 848-857.
13. Kusuhara, H, & Sugiyama, Y. (2002). Role of transporters in the tissue-selective distribution and elimination of drugs: Transporters in the liver, small intestine, brain, and kidney. J. Control. Rel., 78, 43-54.
14. Lalezari, J. P., Stagg, R. J., Holland, G. N., Kramer, F., Ives, D. V., Youle, M., Robinson, M. R., Drew, W. L., & Jaffe, H. S. (1997). Intravenous cedofovir for peripheral cytomegalovirus retinitis in patients with AIDS: A randomized, controlled trial. Ann. Intern. Med., 126, 257-263.
15. Lee, L., Cook, J. A., & Smith D. E. (1986). Renal transport kinetics of furosemide in the isolated perfused rat kidney. J. Pharmacokinet. Biopharm., 14, 157-174.
16. Ljubojevic, M., Herak-Kramberger, C. M., Hagos, Y., Bahn, A., Endou, H., Burkhardt, H., & Sabolic, I. (2004). Rat renal cortical OAT1 and OAT3 expression exhibit gender differences exhibited by both androgen stimulation and estrogen inhibition. Am. J. Physiol. Renal, 287, F124-F138.
17. Masereeuw, R., & Russel, F. G. M. (2001). Mechanisms and clinical implications of renal drug excretion. Drug Metab. Rev., 33, 299-351.
18. Meibohm, B., Beierle, I., & Derendorf, H. (2002). How important are gender differences in pharmacokinetics? Clin. Pharmacokinet., 41, 329-342.
19. Morris M. E., Lee, H. J., & Predko, L. M. (2003). Gender differences in the membrane transport of endogenous and exogenous compounds. Pharmacol. Rev., 55, 229-240.
20. Nishiitsutsuji-Uwo, J. M., Ross, B. D., & Krebs, H. A. (1967). Metabolic activities of the isolated perfused rat kidney. Biochem. J., 103, 852-862.
21. Poola, N. R., Bhuiyan, D., Ortiz, S. R., Savant, I. A., Sidhom, M., Kirschenbaum, H. L., Kalis, M., & Taft, D. R. (2002). A novel HPLC assay for pentamidine: comparative effects of creatinine and inulin on GFR estimation and pentamidine renal excretion in the isolated perfused rat kidney. J. Pharm. Pharmaceut. Sci., 5, 135-145.
22. Pritchard, J. B., & Miller, D. S. (1997). Renal secretion of organic anions and cations. Kidney Int., 49, 1649-1654.
23. Reyes, J. L., Melendez, E., Alegria, A., & Jaramillo-Juarez, F. (1998). Influence of sex differences on the renal secretion of organic anions. Endocrinology, 139, 1581-1587.
24. Robertson, E. E., & Rankin, G. O. (2006). Human renal organic anion transporters: Characteristics and contributions to drug and drug metabolite excretion. Pharmacol. Ther., 109, 399-412.
25. Savant, I. A., Kalis, M., Almoazen, H., Ortiz, S. R., AbuTarif, M., & Taft, D. R. (2001). Alternative high-performance liquid chromatographic assay for p-aminohippuric acid (PAH): Effect of aging on PAH excretion in the isolated perfused rat kidney. J. Pharmaceut. Biomed. Anal., 26, 687-699.
26. Schwartz, J. B. (2003). The influence of sex on pharmacokinetics. Clin. Pharmacokinet., 42, 107-121.
27. Sekine, T., Cha, S. H., & Endou, H. (2000). The multispecific organic anion transporter (OAT) family. Pflugers Arch., 440, 337-350.
28. Smith, D. E., Kin, E. T., & Benet, L. Z. (1980). Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay. Drug Metab. Dispos., 8, 337-342.
29. Statkevich, P., Fournier, D. J., & Sweeney, K. R. (1993). Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther., 265, 1118-1124.
30. Sweeney, K. R., Hsyu, P., Statkevich, P., & Taft, D. R. (1995). Renal disposition and drug interaction screening of (-)-2′-deoxy-3′- thiacytidine (3TC) in the isolated perfused rat kidney. Pharm. Res., 12, 1958-1963.
31. Taft, D. R. (2004). The isolated perfused rat kidney model: a useful tool for drug discovery and development. Curr. Drug Discov. Technol., 1, 97-111.
32. Tucker, G. T. (1981). Measurement of renal clearance of drugs Br. J. Clin. Pharmacol., 12, 761-770.
33. Tune, B. M. (1997). Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention. Pediatr. Nephrol., 11, 768-772.
34. Uwai, Y., Saito, H., Hashimoto, Y., & Inui, K. (2000). Interaction and transport of thiazide diuretics, loop diuretic sand acetazolamide via rat renal organic anion transporter rOAT1. J. Pharmacol. Exp. Ther., 295, 261-265.
35. van Aubel, R. A. M. H., Masereeuw, R., & Russel, F. G. M. (2000). Molecular pharmacology of renal organic anion transporters. Am. J. Physiol., 279, F216-F232.